HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a Regulate the NY-ESO1 Gene Expression

Overview

Journal Mol Oncol

Specialties Molecular Biology
Oncology

Date 2013 Jan 15

PMID 23312906

Citations 28

Authors

Pierre-Francois Cartron

Christophe Blanquart

Eric Hervouet

Marc Gregoire

Francois M Vallette

Affiliations

Soon will be listed here.

Abstract

The NY-ESO1 gene is a cancer/testis antigen considered to be suitable target for the immunotherapy of human malignancies. Despite the identification of the epigenetical silencing of the NY-ESO1 gene in a large variety of tumors, the molecular mechanism involved in this phenomenon is not fully elucidated. In two non epithelial cancers (glioma and mesothelioma), we found that the epigenetic regulation of the NY-ESO1 gene requires the sequential recruitment of the HDAC1-mSin3a-NCOR, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a complexes. Thus, our data illustrate the orchestration of a sequential epigenetic mechanism including the histone deacetylation and methylation, and the DNA methylation processes.

Citing Articles

The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy.

Oleksiewicz U, Kuciak M, Jaworska A, Adamczak D, Bisok A, Mierzejewska J Int J Mol Sci. 2024; 25(21).

PMID: 39519018 PMC: 11546771. DOI: 10.3390/ijms252111466.

Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma.

Zhuo S, Yang S, Chen S, Ding Y, Cheng H, Yang L Discov Oncol. 2024; 15(1):602.

PMID: 39472405 PMC: 11522268. DOI: 10.1007/s12672-024-01449-4.

NY-ESO-1 antigen: A promising frontier in cancer immunotherapy.

Alsalloum A, Shevchenko J, Sennikov S Clin Transl Med. 2024; 14(9):e70020.

PMID: 39275923 PMC: 11399778. DOI: 10.1002/ctm2.70020.

Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy.

Kang Z, Fu P, Ma H, Li T, Lu K, Liu J bioRxiv. 2023; .

PMID: 37873068 PMC: 10592889. DOI: 10.1101/2023.10.03.560719.

Epigenetic and Transcriptomic Programming of HSC Quiescence Signaling in Large for Gestational Age Neonates.

Pelletier A, Carrier A, Zhao Y, Canouil M, Derhourhi M, Durand E Int J Mol Sci. 2022; 23(13).

PMID: 35806330 PMC: 9267056. DOI: 10.3390/ijms23137323.

References

Hervouet E, Vallette F, Cartron P . Dnmt1/Transcription factor interactions: an alternative mechanism of DNA methylation inheritance. Genes Cancer. 2011; 1(5):434-43. PMC: 3092212. DOI: 10.1177/1947601910373794. View

Hervouet E, Vallette F, Cartron P . Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics. 2009; 4(7):487-99. DOI: 10.4161/epi.4.7.9883. View

Maio M, Coral S, Fratta E, Altomonte M, Sigalotti L . Epigenetic targets for immune intervention in human malignancies. Oncogene. 2003; 22(42):6484-8. DOI: 10.1038/sj.onc.1206956. View

Hegi M, Diserens A, Gorlia T, Hamou M, De Tribolet N, Weller M . MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352(10):997-1003. DOI: 10.1056/NEJMoa043331. View

Cronwright G, Le Blanc K, Gotherstrom C, Darcy P, Ehnman M, Brodin B . Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression. Cancer Res. 2005; 65(6):2207-15. DOI: 10.1158/0008-5472.CAN-04-1882. View

Karpf A . A potential role for epigenetic modulatory drugs in the enhancement of cancer/germ-line antigen vaccine efficacy. Epigenetics. 2007; 1(3):116-20. PMC: 1963490. DOI: 10.4161/epi.1.3.2988. View

Bostick M, Kim J, Esteve P, Clark A, Pradhan S, Jacobsen S . UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science. 2007; 317(5845):1760-4. DOI: 10.1126/science.1147939. View

Cartron P, Blanquart C, Hervouet E, Gregoire M, Vallette F . HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression. Mol Oncol. 2013; 7(3):452-63. PMC: 5528493. DOI: 10.1016/j.molonc.2012.11.004. View

Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo T . The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature. 2007; 450(7171):908-12. DOI: 10.1038/nature06397. View

10.

Guillot F, Boutin B, Blanquart C, Fonteneau J, Robard M, Gregoire M . Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth. Vaccine. 2011; 29(33):5534-43. DOI: 10.1016/j.vaccine.2011.05.029. View

11.

Greer E, Shi Y . Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012; 13(5):343-57. PMC: 4073795. DOI: 10.1038/nrg3173. View

12.

Ecke I, Petry F, Rosenberger A, Tauber S, Monkemeyer S, Hess I . Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. Cancer Res. 2009; 69(3):887-95. DOI: 10.1158/0008-5472.CAN-08-0946. View

13.

Vaissiere T, Sawan C, Herceg Z . Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res. 2008; 659(1-2):40-8. DOI: 10.1016/j.mrrev.2008.02.004. View

14.

Natsume A, Kondo Y, Ito M, Motomura K, Wakabayashi T, Yoshida J . Epigenetic aberrations and therapeutic implications in gliomas. Cancer Sci. 2010; 101(6):1331-6. PMC: 11159342. DOI: 10.1111/j.1349-7006.2010.01545.x. View

15.

Miller K, Tjeertes J, Coates J, Legube G, Polo S, Britton S . Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat Struct Mol Biol. 2010; 17(9):1144-51. PMC: 3018776. DOI: 10.1038/nsmb.1899. View

16.

Okada H, Kohanbash G, Zhu X, Kastenhuber E, Hoji A, Ueda R . Immunotherapeutic approaches for glioma. Crit Rev Immunol. 2009; 29(1):1-42. PMC: 2713019. DOI: 10.1615/critrevimmunol.v29.i1.10. View

17.

Dovey O, Foster C, Cowley S . Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc Natl Acad Sci U S A. 2010; 107(18):8242-7. PMC: 2889513. DOI: 10.1073/pnas.1000478107. View

18.

Mund C, Brueckner B, Lyko F . Reactivation of epigenetically silenced genes by DNA methyltransferase inhibitors: basic concepts and clinical applications. Epigenetics. 2007; 1(1):7-13. DOI: 10.4161/epi.1.1.2375. View

19.

Hervouet E, Vallette F, Cartron P . Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastoma multiforme. Cell Death Dis. 2011; 1:e8. PMC: 3032516. DOI: 10.1038/cddis.2009.7. View

20.

Kang Y, Hong J, Chen G, Nguyen D, Schrump D . Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells. Oncogene. 2007; 26(30):4394-403. DOI: 10.1038/sj.onc.1210218. View